# First United Corp: financial statements, quarterly

FUNC · Nasdaq · CIK 763907 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/func.md) · [Financials](/companies/func/financials.md) · [Filings](/companies/func/filings.md) · [Insiders](/companies/func/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/func/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $k | [7,180](/filings/0001558370-23-018555.md) | [7,997 d](/filings/0001558370-24-003390.md) | [8,086](/filings/0001558370-24-007330.md) | [7,875](/filings/0001558370-24-011343.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [1,321](/filings/0001558370-24-014855.md) | [317 d](/filings/0001558370-25-003375.md) | [1,162](/filings/0001558370-25-006727.md) | [1,607](/filings/0001558370-25-011377.md) | [1,932](/filings/0001104659-25-106985.md) | [1,960 d](/filings/0001104659-26-025836.md) | [1,892](/filings/0001104659-26-057909.md) | [1,975](/filings/0001104659-26-092127.md) | [2,294](/filings/0001104659-25-106985.md) | [1,857 d](/filings/0001104659-26-025836.md) | [2,179](/filings/0001104659-26-057909.md) | [1,731](/filings/0001104659-26-092127.md) |
| Net income | $k | [4,513](/filings/0001558370-24-014855.md) | [1,758 d](/filings/0001558370-25-003375.md) | [3,698](/filings/0001104659-25-106985.md) | [4,914](/filings/0001104659-25-106985.md) | [5,771](/filings/0001104659-25-106985.md) | [6,186 d](/filings/0001104659-26-025836.md) | [5,806](/filings/0001104659-26-092127.md) | [5,984](/filings/0001104659-26-092127.md) | [6,948](/filings/0001104659-25-106985.md) | [5,777 d](/filings/0001104659-26-025836.md) | [6,663](/filings/0001104659-26-092127.md) | [5,667](/filings/0001104659-26-092127.md) |
| Diluted EPS | $ per share | [0.67](/filings/0001558370-24-014855.md) | not reported | [0.56](/filings/0001558370-25-006727.md) | [0.75](/filings/0001558370-25-011377.md) | [0.89](/filings/0001104659-25-106985.md) | not reported | [0.89](/filings/0001104659-26-057909.md) | [0.92](/filings/0001104659-26-092127.md) | [1.07](/filings/0001104659-25-106985.md) | not reported | [1.03](/filings/0001104659-26-057909.md) | [0.88](/filings/0001104659-26-092127.md) |
| Basic EPS | $ per share | [0.67](/filings/0001558370-24-014855.md) | not reported | [0.56](/filings/0001558370-25-006727.md) | [0.75](/filings/0001558370-25-011377.md) | [0.89](/filings/0001104659-25-106985.md) | not reported | [0.90](/filings/0001104659-26-057909.md) | [0.92](/filings/0001104659-26-092127.md) | [1.07](/filings/0001104659-25-106985.md) | not reported | [1.03](/filings/0001104659-26-057909.md) | [0.88](/filings/0001104659-26-092127.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [80.7](/filings/0001558370-23-018555.md) | [49.8](/filings/0001558370-25-003375.md) | [86.9](/filings/0001558370-24-007330.md) | [45.1](/filings/0001558370-24-011343.md) | [62.4](/filings/0001558370-24-014855.md) | [78.3](/filings/0001104659-26-025836.md) | [84.4](/filings/0001558370-25-006727.md) | [79.1](/filings/0001558370-25-011377.md) | [95.2](/filings/0001104659-25-106985.md) | [132](/filings/0001104659-26-092127.md) | [89.8](/filings/0001104659-26-057909.md) | [85.2](/filings/0001104659-26-092127.md) |
| Total assets | $m | [1,928](/filings/0001558370-23-018555.md) | [1,906](/filings/0001558370-25-003375.md) | [1,913](/filings/0001558370-24-007330.md) | [1,869](/filings/0001558370-24-011343.md) | [1,916](/filings/0001558370-24-014855.md) | [1,973](/filings/0001104659-26-025836.md) | [1,980](/filings/0001558370-25-006727.md) | [2,007](/filings/0001558370-25-011377.md) | [2,024](/filings/0001104659-25-106985.md) | [2,087](/filings/0001104659-26-092127.md) | [2,039](/filings/0001104659-26-057909.md) | [2,082](/filings/0001104659-26-092127.md) |
| Total liabilities | $m | [1,773](/filings/0001558370-23-018555.md) | [1,744](/filings/0001558370-25-003375.md) | [1,747](/filings/0001558370-24-007330.md) | [1,704](/filings/0001558370-24-011343.md) | [1,742](/filings/0001558370-24-014855.md) | [1,794](/filings/0001104659-26-025836.md) | [1,796](/filings/0001558370-25-006727.md) | [1,816](/filings/0001558370-25-011377.md) | [1,825](/filings/0001104659-25-106985.md) | [1,884](/filings/0001104659-26-092127.md) | [1,834](/filings/0001104659-26-057909.md) | [1,870](/filings/0001104659-26-092127.md) |
| Long-term debt | $m | [111](/filings/0001558370-23-018555.md) | [111](/filings/0001558370-25-003375.md) | [70.9](/filings/0001558370-24-007330.md) | [70.9](/filings/0001558370-24-011343.md) | [121](/filings/0001558370-24-014855.md) | [121](/filings/0001104659-26-025836.md) | [121](/filings/0001558370-25-006727.md) | [121](/filings/0001558370-25-011377.md) | [95.9](/filings/0001104659-25-106985.md) | [95.9](/filings/0001104659-26-092127.md) | [30.9](/filings/0001104659-26-057909.md) | [30.9](/filings/0001104659-26-092127.md) |
| Short-term borrowings | $m | [53.3](/filings/0001558370-23-018555.md) | [45.4](/filings/0001558370-25-003375.md) | [79.5](/filings/0001558370-24-007330.md) | [62.6](/filings/0001558370-24-011343.md) | [50.2](/filings/0001558370-24-014855.md) | [65.4](/filings/0001104659-26-025836.md) | [20.3](/filings/0001558370-25-006727.md) | [51.0](/filings/0001558370-25-011377.md) | [20.2](/filings/0001104659-25-106985.md) | [17.7](/filings/0001104659-26-092127.md) | [19.6](/filings/0001104659-26-057909.md) | [69.2](/filings/0001104659-26-092127.md) |
| Shareholders' equity | $m | [155](/filings/0001558370-24-014855.md) | [162](/filings/0001104659-26-025836.md) | [165](/filings/0001104659-25-106985.md) | [164](/filings/0001104659-25-106985.md) | [174](/filings/0001104659-25-106985.md) | [179](/filings/0001104659-26-092127.md) | [184](/filings/0001104659-26-092127.md) | [191](/filings/0001104659-26-092127.md) | [199](/filings/0001104659-25-106985.md) | [204](/filings/0001104659-26-092127.md) | [205](/filings/0001104659-26-092127.md) | [212](/filings/0001104659-26-092127.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [8.7 d](/filings/0001558370-24-014855.md) | [5.7 d](/filings/0001558370-25-003375.md) | [3.6](/filings/0001558370-25-006727.md) | [7.2 d](/filings/0001558370-25-011377.md) | [2.3 d](/filings/0001104659-25-106985.md) | [9.2 d](/filings/0001104659-26-025836.md) | [7.0](/filings/0001104659-26-057909.md) | [1.0 d](/filings/0001104659-26-092127.md) | [1.5 d](/filings/0001104659-25-106985.md) | [9.9 d](/filings/0001104659-26-025836.md) | [13.9](/filings/0001104659-26-057909.md) | [4.8 d](/filings/0001104659-26-092127.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001558370-24-014855.md) | [0.0 d](/filings/0001558370-25-003375.md) | [0.1](/filings/0001558370-25-006727.md) | [0.1 d](/filings/0001558370-25-011377.md) | [1.7 d](/filings/0001104659-25-106985.md) | [0.0 d](/filings/0001104659-26-025836.md) | [0.6](/filings/0001104659-26-057909.md) | [0.3 d](/filings/0001104659-26-092127.md) | [1.3 d](/filings/0001104659-25-106985.md) | [1.7 d](/filings/0001104659-26-025836.md) | [0.9](/filings/0001104659-26-057909.md) | [0.1 d](/filings/0001104659-26-092127.md) |
| Dividends paid | $m | [1.3 d](/filings/0001558370-24-014855.md) | [1.3 d](/filings/0001558370-25-003375.md) | [1.3](/filings/0001558370-25-006727.md) | [1.3 d](/filings/0001558370-25-011377.md) | [1.3 d](/filings/0001104659-25-106985.md) | [1.4 d](/filings/0001104659-26-025836.md) | [1.4](/filings/0001104659-26-057909.md) | [1.4 d](/filings/0001104659-26-092127.md) | [1.4 d](/filings/0001104659-25-106985.md) | [1.7 d](/filings/0001104659-26-025836.md) | [1.7](/filings/0001104659-26-057909.md) | [1.7 d](/filings/0001104659-26-092127.md) |
| Share repurchases | $m | not reported | [1.5 d](/filings/0001558370-25-003375.md) | not reported | not reported | [(0.0) d](/filings/0001104659-25-106985.md) | [0.0 d](/filings/0001104659-26-025836.md) | not reported | not reported | not reported | not reported | [2.2](/filings/0001104659-26-057909.md) | [0.4 d](/filings/0001104659-26-092127.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q3 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [6,669](/filings/0001558370-23-018555.md) | [6,697](/filings/0001558370-24-007330.md) | [6,718](/filings/0001558370-24-011343.md) | [6,728](/filings/0001558370-24-014855.md) | [6,655](/filings/0001558370-25-006727.md) | [6,537](/filings/0001558370-25-011377.md) | [6,482](/filings/0001104659-25-106985.md) | [6,490](/filings/0001104659-26-057909.md) | [6,506](/filings/0001104659-26-092127.md) | [6,508](/filings/0001104659-25-106985.md) | [6,494](/filings/0001104659-26-057909.md) | [6,461](/filings/0001104659-26-092127.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,453,836 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001104659-26-092127.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.